Indee
Indee is developing simple hardware for scalable engineered cell therapy.
09/09/2024
Check out our latest blog post on how Hydropore improve sequential multiplex editing yields!
Sequential Multiplex Editing with Hydropore Enables Universal Armored CAR-T Therapies — Indee Labs From previous work, we have shown the efficacy of hydroporation in the generation of functional CAR+ T-cells, with higher yields and similar functionality to those generated by conventional electroporation. Here, we show that hydroporation can be used to generate universal CAR+T cells through multip
06/27/2024
Check out our latest pre-print on how Hydropore enhances CAR-T function with Justin Eyquem at UCSF and Leonardo Ferreira at Medical University of South Carolina (MUSC)! https://hubs.li/Q02DBzxG0
11/06/2023
Hydropore enhances CAR-T cell function in vitro. Want to learn more? Check out our latest blog post!
Microfluidic Vortex Shedding Enhances Genome-Edited Chimeric Antigen Receptor T Cell Function — Indee Labs Recent studies suggest a strong connection between CAR-T proliferation, how long they last inside the patient’s body, and how well the patient responds to the treatment [3,16]. To better understand the connection, scientists have examined the ability of CAR-T cells to activate the appropriate immu...
12/23/2022
Happy Holidays from Indee!
12/01/2022
Indee Labs Partners With Monomer Bio to Automate Engineered Immune Cell Culture! Indee
Indee Labs Partners With Monomer Bio to Automate Engineered Immune Cell Culture — Indee Labs Indee Labs partners with Monomer Bio to automate Hydropore workflows for engineered T cells and similar immune cell types.
11/17/2022
Are you attending in person or virtually? Schedule a meeting with the team to learn more our efforts on Hydropore for Research Use Only and Cell Therapy!
BIO Partnering at JPM | BIO The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
11/02/2022
Indee Labs Awarded $2M Contract to Scale up and out Hydropore for Cell Therapy
Indee Labs Awarded $2M Contract to Scale up and out Hydropore for Cell Therapy — Indee Labs Indee Labs announces a $2M contract with the National Cancer Institute to scale up and out the Hydropore platform for cell therapy with Eyquem Lab at UCSF.
08/22/2022
MUSC immunology researcher receives SBIR grant to push boundaries of regulatory T-cell therapy An MUSC Hollings Cancer Center researcher is among the first to use a new device meant to improve Treg gene editing.
06/08/2021
We are excited to introduce Hydropore™ for cell biology and cell therapy research, now available for Research Use Only! Check out our latest blog post to learn more!
Introducing Hydropore™ for Cell Biology and Cell Therapy Research — Indee Labs Hydropore™ is a novel, non-viral delivery platform now available for Research Use Only (RUO). Hydropore™ offers researchers a reliable alternative to electroporation, and can rapidly and efficiently introduce nucleic acids, proteins and gene-editing complexes into cells for a variety of applicat...
02/08/2021
Check out our updated bioRxiv pre-print on CRISPR-Cas9 genome editing with µVS! Let us know what you think and be sure to explore our new website.
Genome editing human primary T cells with microfluidic vortex shedding & CRISPR Cas9 Microfluidic vortex shedding ( μVS ) can rapidly deliver mRNA to T cells with high yield. The mechanistic underpinning of μVS intracellular delivery remains undefined and μVS -Cas9 genome editing requires further studies. Herein, we evaluated a series of μVS devices containing splitter plates to...
01/05/2021
Indee Labs Announces Successful Early Access Program Launch
https://hubs.li/H0DjtBK0
Click here to claim your Sponsored Listing.
Category
Contact the practice
Website
Address
626 Bancroft Way, Suite A
Berkeley, CA
94710